Department of Medical Biosciences,
Division of Immunotherapy,
Oncode Institute,
Division of Immunotherapy, Oncode Institute
Mark A. J. Gorris has not added Biography.
If you are Mark A. J. Gorris and would like to personalize this page please email our Author Liaison for assistance.
Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines.
Cancer research Aug, 2016 | Pubmed ID: 27325645
Human blood myeloid and plasmacytoid dendritic cells cross activate each other and synergize in inducing NK cell cytotoxicity.
Oncoimmunology , 2016 | Pubmed ID: 27853652
Migrating into the Tumor: a Roadmap for T Cells.
Trends in cancer Nov, 2017 | Pubmed ID: 29120755
Eight-Color Multiplex Immunohistochemistry for Simultaneous Detection of Multiple Immune Checkpoint Molecules within the Tumor Microenvironment.
Journal of immunology (Baltimore, Md. : 1950) Jan, 2018 | Pubmed ID: 29141863
Spontaneous Regression of Ovarian Carcinoma After Septic Peritonitis; A Unique Case Report.
Frontiers in oncology , 2018 | Pubmed ID: 30555799
Peptide-mediated delivery of therapeutic mRNA in ovarian cancer.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V Aug, 2019 | Pubmed ID: 31103743
Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer.
Journal for immunotherapy of cancer Nov, 2019 | Pubmed ID: 31727154
Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial.
Cancer immunology, immunotherapy : CII Mar, 2020 | Pubmed ID: 31980913
Human pDCs Are Superior to cDC2s in Attracting Cytolytic Lymphocytes in Melanoma Patients Receiving DC Vaccination.
Cell reports Jan, 2020 | Pubmed ID: 31995747
EpCAM-Binding DARPins for Targeted Photodynamic Therapy of Ovarian Cancer.
Cancers Jul, 2020 | Pubmed ID: 32630661
Clusters of Tolerogenic B Cells Feature in the Dynamic Immunological Landscape of the Pregnant Uterus.
Cell reports Sep, 2020 | Pubmed ID: 32997982
Immune cell composition in the endometrium of patients with a complete molar pregnancy: Effects on outcome.
Gynecologic oncology Feb, 2021 | Pubmed ID: 33213898
Immunomodulatory aged neutrophils are augmented in blood and skin of psoriasis patients.
The Journal of allergy and clinical immunology Oct, 2021 | Pubmed ID: 33745888
Challenges of Neoantigen Targeting in Lynch Syndrome and Constitutional Mismatch Repair Deficiency Syndrome.
Cancers May, 2021 | Pubmed ID: 34067951
Paired primary and metastatic lesions of patients with ipilimumab-treated melanoma: high variation in lymphocyte infiltration and HLA-ABC expression whereas tumor mutational load is similar and correlates with clinical outcome.
Journal for immunotherapy of cancer May, 2022 | Pubmed ID: 35550553
PD-L1 in gestational trophoblastic disease: an antibody evaluation.
Acta obstetricia et gynecologica Scandinavica Sep, 2022 | Pubmed ID: 35689468
Intratumoral T cell depletion following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer is associated with poor clinical outcome.
Cancer immunology, immunotherapy : CII Jan, 2023 | Pubmed ID: 35771253
Homologous recombination repair deficient prostate cancer represents an immunologically distinct subtype.
Oncoimmunology , 2022 | Pubmed ID: 35800157
Tumor microenvironment shows an immunological abscopal effect in patients with NSCLC treated with pembrolizumab-radiotherapy combination.
Journal for immunotherapy of cancer Oct, 2022 | Pubmed ID: 36252995
Immunological and Genomic Analysis Reveals Clinically Relevant Distinctions between Angiosarcoma Subgroups.
Cancers Nov, 2022 | Pubmed ID: 36497420
Immunological responses to adjuvant vaccination with combined CD1c myeloid and plasmacytoid dendritic cells in stage III melanoma patients.
Oncoimmunology , 2022 | Pubmed ID: 36524210
Topography of immune cell infiltration in different stages of coronary atherosclerosis revealed by multiplex immunohistochemistry.
International journal of cardiology. Heart & vasculature Feb, 2023 | Pubmed ID: 36820389
Mark A. J. Gorris1,2,
Evgenia Martynova*,1,3,
Mark W. D. Sweep*,1,4,
Iris A. E. van der Hoorn1,5,
Shabaz Sultan1,3,
Mike J. D. E. Claassens1,
Lieke L. van der Woude1,2,6,
Kiek Verrijp1,2,6,
Carl G. Figdor1,3,
Johannes Textor1,3,
I. Jolanda M. de Vries1
1Department of Medical BioSciences, Radboudumc,
2Division of Immunotherapy, Oncode Institute, Radboudumc,
3Data Science, Institute for Computing and Information Sciences, Radboud University,
4Department of Medical Oncology, Radboudumc,
5Department of Pulmonary Diseases, Radboudumc,
6Department of Pathology, Radboudumc
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved